© Copyright Our Wall
Health staff are of the opinion that, the emanation of novel mutations of Corona virus disease in Southern African Region, have resulted to an upsurge in the number of cases of Corona virus disease and demise that were accounted for across many countries in Southern African Region.
Recently, there has been another wave of the global pandemic, in at least forty-40 African countries, inclusive of all the countries in the southern African region, this belief, was stated by the Africa Centre for Disease Control (CDC). The emerging second wave of the Corona virus global pandemic, is believed to be associated with the emergence of novel variants of the Corona virus, these new mutations, are more transmissible . According to the World Health Organization (W.H.O), in recent months, a new mutation of the virus emerged in South Africa and this mutation has led to an upsurge in the recorded numbers of cases, in the Sub-Saharan Africa.
In other areas of the African continent, this novel mutation of the Covid-19, has been officially recorded in Tanzania, Mozambique, Zambia, Botswana, Kenya, Comoros and Ghana; there exists the possibility of the new mutation of Corona virus disease reaching other countries in the African continent, however, most countries in Africa, do not have the much required financial resources and well trained medical personnel, that are required to perform highly specialized arrangement of the D.N.A, required to discover and pronounce the novel mutations of the Corona virus.
As announced by the W.H.O, in recently confirmed medical laboratory diagnostic virology, results have indicated that, the Corona virus disease variant of the virus in South Africa is very transmissible amongst the citizens. Recently, in just concluded study conducted by the University of Witwatersrand, the Oxford-Astra Zeneca Corona virus disease vaccine, the first Covid-19 vaccine that was received in South Africa, provides little fortification against mellow and light cases of Covid-19, that manifested from the new mutants of the Corona virus disease. The recent research carried out by the University of Witwatersrand, did not study the vaccine's potency, in combating severe Covid-19 infections. The Oxford-AstraZeneca Corona virus vaccine, is a vaccine that was produced by a joint venture agreement between the University of Oxford and AstraZeneca Plc; AstraZeneca Plc, is a British-Swedish multinational pharmaceutical and biotechnology company, that has its headoffice situated at the University of Cambridge Biomedical Campus, in Cambridge England.
Right now, there is an urgent and pressing demand, for individuals, banks, insurance companies, financial institutions, hedge funds, corporate organizations, mining companies, venture capitalists, international donors and philanthropists, to support the efforts of doctors and health staff, across the continent of Africa, that are working restlessly to extinguish the Covid-19 and ensure that the Corona virus is totally stamped out for the wellbeing of people of Africa and the African continent in its entirety.